EUVIMEDOpdag EUVIMED
Open access · CC BY-NC-ND 4.0

Gene Variant Spectrum in Probands With Familial Exudative Vitreoretinopathy Using an Expanded Panel

Sarah van der Ende, Karen Bedard, Karin Wallace, Michael P Mackley, Mathew Nightingale, Daniel Gaston, M Jill Beis, Marissa A Leblanc, Roxanne Gillett, Alex V Levin, Ian H Clark, Élise Héon and 6 more

Investigative Ophthalmology & Visual Science · 2025-02-07 · 66 (2) · 23

DOI: 10.1167/iovs.66.2.23 ↗

At a glance

Journal article in Investigative Ophthalmology & Visual Science, published on 2025-02-07. Written by Sarah van der Ende and 17 co-authors. Institution: Department of Biochemistry & Molecular Biology, Dalhousie University, Halifax, Nova Scotia, Canada. Major MEDLINE topics: Eye Proteins, Retinal Diseases, Mutation, Genetic Variation. Cited 6 times so far (Crossref); 67 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Purpose

To investigate the gene variant spectrum in patients with familial exudative vitreoretinopathy (FEVR).

Methods

Probands clinically diagnosed with FEVR and their relatives were enrolled and clinical information and DNA collected. An expanded FEVR panel was used, including six recognized FEVR genes (FZD4, NDP, LRP5, TSPAN12, ZNF408, and CTNNB1) and 19 genes previously associated with ocular features overlapping FEVR (FEVR-associated genes). Variants identified using targeted next-generation sequencing and/or Sanger sequencing were analyzed and classified using the American College of Medical Genetics and Clinical Genome Resource Sequence Variant Interpretation (ClinGen SVI) working group recommendations to detect disease-causing variants (DCVs).

Results

Analyses of data from a cohort of 94 probands provided a molecular diagnosis for 39 (41.5%) probands: 34 (87.2%) had a single DCV, whereas 5 (12.8%) harbored more than 1 DCV. Of 41 total DCVs in solved probands, 33 (80.5%) were in 4 of the 6 recognized genes, LRP5, FZD4, TSPAN12, and NDP, whereas 8 were found in FEVR-associated genes, 6 in KIF11, and 2 (LAMA1 and DOCK6) each in association with a KIF11 DCV. Reanalyzing variants using the latest criteria impacted the variant classification in five probands (5.3%), changing variants that were once deemed likely pathogenic to variants of uncertain significance.

Conclusions

The expanded FEVR gene panel detected DCVs in nearly one-half of our cohort. Including the criteria used in classification will improve transparency of variant calls as more data become available. Four FEVR genes account for most cases, and the role of rare FEVR genes and candidate genes requires further study.

Subjects

MeSH terms (MEDLINE)

Eye ProteinsRetinal DiseasesMutationGenetic VariationHumansFemaleMaleFamilial Exudative VitreoretinopathiesTetraspaninsLow Density Lipoprotein Receptor-Related Protein-5Frizzled ReceptorsPedigreeHigh-Throughput Nucleotide SequencingChildChild, PreschoolNerve Tissue ProteinsInfantEye Diseases, HereditaryAdultDNA Mutational AnalysisAdolescentDNA-Binding ProteinsTranscription Factors

Substances

TetraspaninsTSPAN12 protein, humanLow Density Lipoprotein Receptor-Related Protein-5Eye ProteinsFZD4 protein, humanLRP5 protein, humanFrizzled ReceptorsZNF408 protein, humanNerve Tissue ProteinsNDP protein, human

Authors and institutions

  • Department of Biochemistry & Molecular Biology, Dalhousie University, Halifax, Nova Scotia, Canada.
  • Department of Pathology, Dalhousie University, Department of Pathology and Laboratory Medicine, IWK Health Centre, Halifax, Nova Scotia, Canada.
  • Department of Surgery, IWK Health Centre, Halifax, Nova Scotia, Canada.
  • Division of Clinical & Metabolic Genetics, Department of Paediatrics, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.
  • Genomics Cores Laboratory, Dalhousie University, Halifax, Nova Scotia, Canada.
  • Department of Pathology, Dalhousie University, Department of Pathology and Laboratory Medicine, Nova Scotia Health, Halifax, Nova Scotia, Canada.

Cite

APA

van der Ende, S., Bedard, K., Wallace, K., Mackley, M. P., Nightingale, M., Gaston, D., Beis, M. J., Leblanc, M. A., Gillett, R., Levin, A. V., Clark, I. H., Héon, É., Muni, R. H., Traboulsi, E. I., Lyons, C. J., McMaster, C. R., Robitaille, J. M., & FEVR Consortium (2025). Gene Variant Spectrum in Probands With Familial Exudative Vitreoretinopathy Using an Expanded Panel. Investigative Ophthalmology & Visual Science. https://doi.org/10.1167/iovs.66.2.23

Vancouver

van der Ende S, Bedard K, Wallace K, Mackley MP, Nightingale M, Gaston D, et al. Gene Variant Spectrum in Probands With Familial Exudative Vitreoretinopathy Using an Expanded Panel. Investigative Ophthalmology & Visual Science. 2025. doi:10.1167/iovs.66.2.23

BibTeX
@article{vanderEnde2025,
  author = {van der Ende, Sarah and Bedard, Karen and Wallace, Karin and Mackley, Michael P and Nightingale, Mathew and Gaston, Daniel and Beis, M Jill and Leblanc, Marissa A and Gillett, Roxanne and Levin, Alex V and Clark, Ian H and Héon, Élise and Muni, Rajeev H and Traboulsi, Elias I and Lyons, Christopher J and McMaster, Christopher R and Robitaille, Johane M and FEVR Consortium, FEVR Consortium},
  title = {Gene Variant Spectrum in Probands With Familial Exudative Vitreoretinopathy Using an Expanded Panel},
  journal = {Investigative Ophthalmology & Visual Science},
  year = {2025},
  doi = {10.1167/iovs.66.2.23}
}
Start for free →